文献速递中毒与环境急症重症综合管理与镇静镇痛

远程医疗与COVID-19期间的阿片危机:城乡在急诊救治与毒物中心远程会诊中的差异

Telehealth and the opioid crisis during COVID-19: urban-rural disparities in emergency care and poison center teleconsultations.
PubMed 文献 · Clin Toxicol (Phila) · 2026-01-08
一句话结论COVID-19期间,向美国毒物中心报告的故意阿片过量病例中,城乡重症监护入院、纳洛酮使用和气管插管均减少,提示救治流程可能中断。

该准实验研究分析2018—2022年美国毒物中心报告的故意阿片过量远程会诊数据,采用多变量多项和逻辑回归评估疫情前后及城乡差异。结果显示阿片过量占比仅增加1%(均差0.8%;95%CI:0.7-0.8);疫情期重症监护入院在城市(aOR 0.59;95%CI:0.56-0.63)和农村(aOR 0.67;95%CI:0.61-0.74)均下降;纳洛酮使用在城市(aOR 0.69;95%CI:0.65-0.72)和农村(aOR 0.84;95%CI:0.77-0.92)均减少;气管插管率在农村(aOR 0.74;95%CI:0.62-0.88)和城市(aOR 0.67;95%CI:0.61-0.74)均降低,农村患者始终低于疫情前城市患者。作者认为疫情可能中断了过量救治方案。

要点

  • 疫情期故意阿片过量远程会诊中,重症监护入院在城市aOR 0.59(95%CI:0.56-0.63)、农村aOR 0.67(95%CI:0.61-0.74),均较疫情前下降。
  • 纳洛酮使用疫情期减少:城市aOR 0.69(95%CI:0.65-0.72),农村aOR 0.84(95%CI:0.77-0.92)。
  • 气管插管率疫情期降低:城市aOR 0.67(95%CI:0.61-0.74),农村aOR 0.74(95%CI:0.62-0.88)。
  • 农村患者气管插管 odds 始终低于疫情前城市患者。
  • 阿片过量占全部远程会诊比例仅增加1%(均差0.8%;95%CI:0.7-0.8)。

适用人群与场景

  • 2018—2022年向美国毒物中心报告的故意阿片过量远程会诊病例,涵盖城市和农村地区。

研究设计与关键结果

  • 研究类型为准实验研究,分析2018—2022年美国毒物中心故意阿片过量远程会诊数据。
  • 阿片过量占比增加1%(均差0.8%;95%CI:0.7-0.8)。
  • 重症监护入院:城市aOR 0.59(95%CI:0.56-0.63),农村aOR 0.67(95%CI:0.61-0.74),均低于疫情前。
  • 纳洛酮使用:城市aOR 0.69(95%CI:0.65-0.72),农村aOR 0.84(95%CI:0.77-0.92),均低于疫情前。
  • 气管插管:城市aOR 0.67(95%CI:0.61-0.74),农村aOR 0.74(95%CI:0.62-0.88),均低于疫情前;农村患者始终低于疫情前城市患者。

证据类型、等级与局限

  • 证据类型:准实验研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为COVID-19疫情可能中断了阿片过量救治方案,可能影响阿片相关急症患者的结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Although the full impact of the COVID-19 pandemic on opioid overdose management across urban and rural settings may take years to fully elucidate, poison center teleconsultations provide valuable early indicators of emerging clinical patterns. We examined the epidemiological and clinical effects of the pandemic on teleconsultations involving intentional opioid exposures from United States poison centers.

METHODS: We conducted a quasi-experimental study (2018-2022) of intentional opioid overdoses reported to United States poison centers. Through multivariable multinomial and logistic regression, we assessed the relationships between time (pre-COVID-19 versus after COVID-19 onset) and geography (urban or rural) with change in the following outcomes: opioid cases; clinical disposition (admission to a critical care unit, non-critical care unit, psychiatric admission); and clinical management (naloxone, endotracheal intubation).

RESULTS: While there was only a 1% (mean difference 0.8%; 95% CI: 0.7-0.8) increase in the proportion of opioid overdoses, trends and clinical management were different compared to pre-COVID-19 urban cases. Admission to critical care units declined during the COVID-19 era for both urban (adjusted odds ratio: 0.59; 95% CI: 0.56-0.63) and rural (adjusted odds ratio: 0.67; 95% CI: 0.61-0.74) patients. Naloxone administration decreased during the pandemic in both urban (adjusted odds ratio: 0.69; 95% CI: 0.65-0.72) and rural (adjusted odds ratio: 0.84; 95% CI: 0.77-0.92) settings. Endotracheal intubation rates were lower in rural (adjusted odds ratio: 0.74; 95% CI: 0.62-0.88) and urban (adjusted odds ratio: 0.67; 95% CI: 0.61-0.74) settings during COVID-19, with rural patients consistently showing lower odds compared to pre-COVID urban patients.

DISCUSSION: The COVID-19 pandemic was associated with a reduction in critical interventions for opioid overdoses reported to poison centers, highlighting potential disruptions or changes in overdose management across both urban and rural settings.

CONCLUSIONS: These findings add to evidence that the COVID-19 pandemic may have disrupted overdose care protocols, potentially impacting outcomes for individuals with opioid-related emergencies.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Schanbacher CR, Santos Leon E, Krispin S, et al. Telehealth and the opioid crisis during COVID-19: urban-rural disparities in emergency care and poison center teleconsultations. Clin Toxicol (Phila). 2026. PMID: 41505677. doi:10.1080/15563650.2025.2603516

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。